Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Haemophilia A Clinical Trials

8 recruiting trials for Haemophilia A. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
8
Total Trials
8
Recruiting Now
1
Phase 3 Trials
5
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT07437404

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

This is an Open Label, Uncontrolled Study to Evaluate the the Safety and Efficacy of SCT800 for Prophylaxis Treatment in Severe Previously Untreated Hemophilia Patients.

Sponsor: Sinocelltech Ltd.Enrolling: 361 location
RECRUITINGNCT05621746

An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

This study will collect information on the long term health of joints in people with haemophilia A who have started treatment with Esperoct within twelve months prior to...

Sponsor: Novo Nordisk A/SEnrolling: 1001 location
RECRUITINGPhase 1NCT07238816

A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People

The purpose of this study is to test a new medicine called Inno8. The study will test how eating and drinking before and after taking Inno8 affects how well it is absorbed in the...

Sponsor: Novo Nordisk A/SEnrolling: 801 location
RECRUITINGNCT03695978

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A...

International, post-authorisation non-interventional study to evaluate real-life effectiveness, safety and utilisation patterns of Octapharma's FVIII concentrates Nuwiq, Octanate,...

Sponsor: OctapharmaEnrolling: 20020 locations
RECRUITINGNCT06574984

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

The study has descriptive purposes, with aim of assessing how turoctocog alfa is used in the everyday practice and to provide a baseline for the management of haemophilia A and...

Sponsor: Novo Nordisk A/SEnrolling: 9007 locations
RECRUITINGPhase 1NCT07220564

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

This study will test how different doses of study medicine (Inno8) work in the bodies of people with haemophilia A. The purpose of the study is to see if Inno8 is safe to use for...

Sponsor: Novo Nordisk A/SEnrolling: 3020 locations
RECRUITINGNCT02207894

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

This research program is initiated to evaluate and document data on the success of ITI in 300 haemophilia A patients with newly developed or already existing FVIII-inhibitors...

Sponsor: Haemophilia Centre Rhine MainEnrolling: 3001 location
RECRUITINGNCT06352216

Prevalence of Synovitis in Patients With Haemophilia A

The aim of this study is to evaluate the prevalence of synovitis in adult patients with haemophilia A.

Sponsor: University Hospital, BonnEnrolling: 3001 location